Bionow | News

TotalLab Selected by Leading Global Pharmaceutical Manufacturer to Deliver Custo...

Aug 1st 2025

TotalLab has been chosen by a leading global pharmaceutical company to deliver a custom, automated ATMP workflow solution. This innovative software will ensure GMP and 21 CFR Part 11 complia...

Exciting Expansion at Guy’s and St Thomas’ Advanced Therapy Manufacturing Fa...

Aug 1st 2025

Scitech is proud to be supporting the expansion of the Advanced Therapy Manufacturing Platform at Guy’s and St Thomas’ NHS Foundation Trust (GSTT) – a critical development to meet the ...

The power of organoids – advances in disease modelling research

Jul 11th 2025

The FDA recently announced its plans to replace animal testing in the development of monoclonal antibodies with other methods, including human organoid models.

Jetbio rolls-out its miniReJI 3D bioprinter. Researchers print models of osteoar...

Jun 24th 2025

Jetbio, is commercialising its state-of-the-art 3D bioprinting systems comprising of Reactive Jet Impingement (ReJI), microvalve and inkjet modular integrated bioprint modes for creating cel...

Kuraray and CellRev Partner to support optimised cell culture systems in Regener...

Jun 17th 2025

Partnership will initiate with a commercial pilot running from June to November 2025 with a focus on the Japanese market

New University of Liverpool spin-out developing novel adult stem cell-based Ther...

Feb 15th 2024

The University of Liverpool has launched a new spin-out company, TrophiCell, that has developed a revolutionary approach to harness the therapeutic potential of adult Mesenchymal Stem Cells ...

Biocair takes home two awards at the prestigious Asia-Pacific Cell & Gene Therap...

Sep 22nd 2023

Biocair, a distinguished life science logistics company with over three decades of expertise, was announced as the winner of two awards at the esteemed Asia-Pacific Cell & Gene Therapy Excel...

University secures £2.66m to develop personalised cancer treatment

Sep 15th 2023

University of Liverpool researchers have secured £2.66m Medical Research Council funding to clinically test a novel immunotherapeutic strategy for non-small cell lung cancer – one of the ...

Celebrating 20 years at Biocair: An interview with Christopher Good

Aug 24th 2023

Christopher Good, Director of Cell and Gene Therapy Logistics at Biocair, reflects on his last two decades with the company and how the industry has changed during that time.

BIomatics to support Cell and Gene Therapy Catapult to accelerate programme of O...

Aug 9th 2023

Business transformation consultancy Biomatics is to work alongside innovation and technology organisation, the Cell and Gene Therapy Catapult.

Biocair develops dedicated team for cell and gene therapy logistics

Dec 5th 2022

Biocair has invested heavily in the creation of a specialist logistics team to meet the complex needs of the rapidly expanding cell and gene therapy sector.

UK Supplier expands to provide Chemically Defined & Serum-Free Cell Media Soluti...

Nov 15th 2022

BioPharma Dynamics, a leading life sciences solution provider, proudly expand their extensive portfolio for the Cell & Gene Therapy market to offer a range of chemically defined T-Cell Media...

News